Revelation Biosciences Inc (REVB) — Cash Flow Quality Index
Revelation Biosciences Inc (REVB) has a Cash Flow Quality Index of -0.26x as of March 2023. Operating cash flow of $-1.58 Million is below net income of $6.16 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Revelation Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Revelation Biosciences Inc Cash Flow Quality Index (2015–2018)
Historical Cash Flow Quality Index for Revelation Biosciences Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see REVB cash flow metrics.
Annual Cash Flow Quality Index for Revelation Biosciences Inc (2015–2018)
Year-by-year earnings quality comparison for Revelation Biosciences Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.18x | $32.58 Million | $27.63 Million | ▼ -20.9% |
| 2017 | 1.49x | $24.25 Million | $16.27 Million | ▲ +12.8% |
| 2016 | 1.32x | $11.60 Million | $8.78 Million | ▼ -29.3% |
| 2015 | 1.87x | $11.60 Million | $6.20 Million | — |